133 related articles for article (PubMed ID: 36790217)
1. GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
Keranov S; Widmann L; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Bauer P; Richter MJ; Tello K; Gall H; Ghofrani HA; Wiedenroth CB; Guth S; Seeger W; Hamm CW; Nef H; Dörr O
Biomark Med; 2022 Dec; 16(17):1193-1207. PubMed ID: 36790217
[No Abstract] [Full Text] [Related]
2. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
Widmann L; Keranov S; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Arsalan M; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Seeger W; Hamm CW; Dörr O; Nef H
Clin Res Cardiol; 2023 Oct; 112(10):1382-1393. PubMed ID: 36790465
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension.
Kriechbaum SD; Wiedenroth CB; Peters K; Barde MA; Ajnwojner R; Wolter JS; Haas M; Roller FC; Guth S; Rieth AJ; Rolf A; Hamm CW; Mayer E; Keller T; Liebetrau C
Biomarkers; 2020 Nov; 25(7):578-586. PubMed ID: 32901511
[TBL] [Abstract][Full Text] [Related]
5. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Liebetrau C; Keller T; Troidl C; Riehm J; Rutsatz W; Bauer P; Kriechbaum S; Voss S; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Seeger W; Hamm CW; Nef H
Biomark Med; 2021 Aug; 15(12):1021-1034. PubMed ID: 34289706
[No Abstract] [Full Text] [Related]
7. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension.
Carlomagno G; Messalli G; Melillo RM; Stanziola AA; Visciano C; Mercurio V; Imbriaco M; Ghio S; Sofia M; Bonaduce D; Fazio S
Int J Cardiol; 2013 Sep; 168(2):1545-7. PubMed ID: 23290950
[No Abstract] [Full Text] [Related]
9. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Lv Z; Liang G; Cheng M
Int J Chron Obstruct Pulmon Dis; 2023; 18():2431-2438. PubMed ID: 37955023
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction.
Agoston-Coldea L; Lupu S; Hicea S; Paradis A; Mocan T
Biomark Med; 2014; 8(1):95-106. PubMed ID: 25050435
[TBL] [Abstract][Full Text] [Related]
12. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
Rabkin SW; Tang JKK
Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
[TBL] [Abstract][Full Text] [Related]
13. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
Prins KW; Rose L; Archer SL; Pritzker M; Weir EK; Olson MD; Thenappan T
J Am Heart Assoc; 2019 Jan; 8(2):e011464. PubMed ID: 30646788
[TBL] [Abstract][Full Text] [Related]
14. Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy.
Akdis D; Chen L; Saguner AM; Zhang N; Gawinecka J; Saleh L; von Eckardstein A; Ren J; Matter CM; Hu Z; Chen X; Tanner FC; Manka R; Chen K; Brunckhorst C; Song J; Duru F
Am Heart J; 2022 Feb; 244():66-76. PubMed ID: 34756894
[TBL] [Abstract][Full Text] [Related]
15. Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
Schmeißer A; Rauwolf T; Groscheck T; Fischbach K; Kropf S; Luani B; Tanev I; Hansen M; Meißler S; Schäfer K; Steendijk P; Braun-Dullaeus RC
ESC Heart Fail; 2021 Aug; 8(4):2968-2981. PubMed ID: 33934536
[TBL] [Abstract][Full Text] [Related]
16. SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Richter M; Tello K; Gall H; Ghofrani HA; Mayer E; Seeger W; Hamm CW; Nef H
Biomarkers; 2020 May; 25(3):290-295. PubMed ID: 32248722
[No Abstract] [Full Text] [Related]
17. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
[TBL] [Abstract][Full Text] [Related]
19. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
[TBL] [Abstract][Full Text] [Related]
20. CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Troidl C; Liebetrau C; Kriechbaum S; Keller T; Voss S; Bauer T; Lorenz J; Richter MJ; Tello K; Gall H; Ghofrani HA; Mayer E; Wiedenroth CB; Guth S; Lörchner H; Pöling J; Chelladurai P; Pullamsetti SS; Braun T; Seeger W; Hamm CW; Nef H
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33184116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
